§ PHARMACEUTICALS
USD · Pharmaceuticals

SEPN

SEPTERNA INC
USDSector · Pharmaceuticals
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
105 increased/new, 32 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
RA CAPITAL MANAGEMENT, L.P.7.0M1.8%±0%
TRV GP V, LLC6.2M37.2%±0%
Driehaus Capital Management LLC4.4M0.8%−9%
TRV GP VI, LLC4.2M74.6%±0%
SAMSARA BIOCAPITAL, LLC3.1M7.4%±0%
Goldman Sachs2.9M0.0%n/a
◇ AC INTELLIGENCE

Top institutional owners for SEPN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER83.7% · 84 holders
DEALER / BANK9.3% · 16 holders
QUALITY / COMPOUNDER6.9% · 10 holders
PASSIVE / INDEX6.2% · 7 holders
TACTICAL / MACRO0.8% · 2 holders
SYSTEMATIC / QUANT0.2% · 3 holders
INCOME / DEFENSIVE0.0% · 4 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for SEPN in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention SEPN yet.